Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (141-150 of 450) with videos related to

Pageof 45
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Acta Neuropathologica|August 19, 2022
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomasHelin Dogan, Christina Blume, Areeba Patel, et al.
Acta Neuropathologica|April 29, 2019
Molecular progression of SHH-activated medulloblastomasAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomasAndrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Neuro-Oncology Advances|August 1, 2025
A feasibility study of enzymatic methylation sequencing of cell-free DNA from cerebrospinal fluid of pediatric central nervous system tumor patients for molecular classificationAaron Michael Taylor, Jody T Lombardi, Areeba Patel, et al.
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
Plos One|January 20, 2017
Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with HistopathologyOliver Eidel, Sina Burth, Jan-Oliver Neumann, et al.
Neuro-Oncology|March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomasEmeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Cancers|February 15, 2022
Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion RadiotherapyMaximilian Knoll, Maria Waltenberger, Jennifer Furkel, et al.
Pageof 45

Showing results (141-150 of 450) with videos related to

Sort By:
Pageof 45
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
[<sup>177</sup>Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II TrialNathalie L Albert, Emeline Tabouret, Emilie Le Rhun, et al.
Acta Neuropathologica|August 19, 2022
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomasHelin Dogan, Christina Blume, Areeba Patel, et al.
Acta Neuropathologica|April 29, 2019
Molecular progression of SHH-activated medulloblastomasAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology|September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomasAndrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Neuro-Oncology Advances|August 1, 2025
A feasibility study of enzymatic methylation sequencing of cell-free DNA from cerebrospinal fluid of pediatric central nervous system tumor patients for molecular classificationAaron Michael Taylor, Jody T Lombardi, Areeba Patel, et al.
The Journal of Clinical Investigation|January 3, 2015
Proximity ligation assay evaluates IDH1R132H presentation in gliomasLukas Bunse, Theresa Schumacher, Felix Sahm, et al.
Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.
Plos One|January 20, 2017
Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with HistopathologyOliver Eidel, Sina Burth, Jan-Oliver Neumann, et al.
Neuro-Oncology|March 7, 2024
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomasEmeline Tabouret, Julia Furtner, Thomas Graillon, et al.
Cancers|February 15, 2022
Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion RadiotherapyMaximilian Knoll, Maria Waltenberger, Jennifer Furkel, et al.
Pageof 45